Samer Alsaid: Warfarin Outcomes Reassessed Through COMBINE AF
Samer Alsaid, Cardiologist and Vascular Medicine Specialist, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in JACC: Advances, adding:
“Some projects become more than just papers.
Three years ago, my first project at the TIMI Study Group began with a long-standing idea of Dr. Eugene Braunwald.
He had long recognized that we had one of the world’s largest collections of patients treated with warfarin from the pivotal atrial fibrillation trials—and a unique opportunity to answer questions that remain clinically relevant today, including whether there are patients for whom warfarin may still be a reasonable option, particularly where access to DOACs is limited.
Three years later, that work has culminated in two companion papers from the COMBINE AF collaboration, now published in JACC: Advances.
Dr. Braunwald mentored this work every step of the way—with calls, ideas, and thoughtful edits—until the very end.
Sadly, he did not live to see these papers published.
His mentorship, intellectual curiosity, and unwavering commitment to improving patient care will stay with me for the rest of my career.”
Title: Outcomes With Warfarin in Atrial Fibrillation: Individual Patient Data Analysis From Four Randomized Trials
Authors: Samer AlSaid, Eugene Braunwald, Elaine M. Hylek, Michael G. Palazzolo, Andrea Bellavia, Elliott M. Antman, Anthony P. Carnicelli, John W. Eikelboom, Christopher B. Granger, Manesh R. Patel, Lars Wallentin, Christian T. Ruff, Robert P. Giugliano
Read the full article on JACC: Advances.
Title: Heterogeneity of Treatment Effect of DOACs vs Warfarin in Atrial Fibrillation
Authors: Samer Al Said, Andrea Bellavia, Eugene Braunwald, Elaine M. Hylek, Michael G. Palazzolo, Hwanhee Hong, Elliott M. Antman, Anthony P. Carnicelli, John W. Eikelboom, Christopher B. Granger, Manesh R. Patel, Lars Wallentin, Christian T. Ruff, Robert P. Giugliano
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 14, 2026, 23:49Heghine Khachatryan: New evidance – Antiphospholipid Antibodies and Ischemic Stroke
-
Sep 14, 2026, 23:42Eman M. Elsabbagh: Successful HCT Does Not End at Engraftment
-
Sep 14, 2026, 23:31Antonis Kattamis: Proud to Be Part of this Endeavour and Senior Author of the Pivotal Trial
-
Sep 14, 2026, 23:23Farjah Algahtani: Stroke Incidence and Risk Factors in Saudi Patients with Sickle Cell Disease
-
Sep 14, 2026, 20:53YoonHwa An: Rusfertide in Polycythemia Vera – From Clinical Benefit to Strategic Value
-
Sep 14, 2026, 20:52Andres Alberto Mercado Pompa: External Validation of Prognostic Risk Scores in Cerebral Venous Thrombosis
-
Sep 14, 2026, 20:50Balaji Kirushnan: Advancing Regional Citrate Anticoagulation in CRRT – From Experience to Implementation
-
Sep 14, 2026, 20:48Valerie Dehondt: Nutritional Anemia Is Associated With Increased Risk of Severe COPD Exacerbations
-
Sep 14, 2026, 20:46Nupur Choudhury: Exploring AI-Based Detection of Anemia Using Eye and Fingernail Images